Elevai Labs Inc (ELAB)

Dec 4, 2025, 10:57 AM EST - 3 days ago

PMGC Holdings Inc. [Nasdaq: ELAB] Congratulates General Enterprise Ventures, Inc. [NYSE: CITR] on Its Uplisting to the NYSE American, Highlights Equity Stake

Oct 20, 2025, 7:30 AM EDT - 6 weeks ago

PMGC Holdings Inc. Announces Over $711,000.00 in Sales Backlog at AGA Precision Systems LLC and Provides Corporate Update

Sep 4, 2025, 9:54 AM EDT - 3 months ago

Northstrive Biosciences Announces Completion of Phase II of AI Development Program with YuvaBio Using MitoNova™ Artificial Intelligence (AI) Platform to Develop Therapies for Obesity and Cardiometabolic Diseases

Aug 28, 2025, 10:30 AM EDT - 3 months ago

PMGC Holdings Inc. Announces Anticipated Reverse Stock Split

Aug 25, 2025, 5:00 PM EDT - 3 months ago

Univest Securities, LLC Announces Closing of $1.67 Million Warrant Inducement for its Client PMGC Holdings Inc. (NASDAQ: ELAB)

Aug 22, 2025, 1:48 PM EDT - 3 months ago

PMGC Holdings Inc. Announces $1.67 Million in Gross Proceeds from Warrant Inducement with Institutional Investors Priced At-The Market Under Nasdaq Rules

Aug 13, 2025, 7:44 AM EDT - 4 months ago

PMGC Holdings Inc. Announces Filing of Quarterly Report on Form 10-Q

Jul 30, 2025, 7:45 AM EDT - 4 months ago

PMGC Holdings Inc. Terminates LOI to Focus on Acquiring High-Growth CNC Precision Manufacturing Companies Serving Aerospace, Defense, and Industrial Markets

Jul 18, 2025, 12:53 PM EDT - 5 months ago

PMGC Holdings Inc. Completes Acquisition of CNC Machining Company - AGA Precision Systems LLC

Jul 10, 2025, 8:30 AM EDT - 5 months ago

PMGC Holdings Inc. Completes Acquisition of Custom IT Packaging Company Pacific Sun Packaging with Over $2,000,000 in Combined Revenue for Fiscal Years 2023 and 2024

Jun 24, 2025, 8:30 AM EDT - 5 months ago

PMGC Holdings Inc. Signs Non-Binding LOI to Acquire CNC Aerospace Manufacturer Generating $4.5 Million in Annual Revenue

Jun 18, 2025, 9:52 AM EDT - 6 months ago

PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading Wall Street Bank Behind Many Leading Crypto Strategies

Jun 17, 2025, 9:04 AM EDT - 6 months ago

Northstrive Biosciences Announces Initiation of Phase II of Collaboration to Develop AI Powered Therapies for Obesity and Cardiometabolic Diseases

Jun 16, 2025, 8:00 AM EDT - 6 months ago

PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based AS9100D & ISO 9001:2015 Certified CNC Machine Shop Serving Aerospace, Defense, and Industrial Markets for over 35 years

Jun 9, 2025, 8:00 AM EDT - 6 months ago

PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based Electronics Manufacturing Company

May 22, 2025, 8:16 AM EDT - 7 months ago

NorthStrive Biosciences Announces Completion of Phase I Strategic Review for EL-22 Targeting Muscle Loss Associated with GLP-1 Weight Loss Drugs and Age-Related Sarcopenia

May 14, 2025, 8:00 AM EDT - 7 months ago

PMGC Capital LLC, a Subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), To File Schedule 13D Reporting 5.09% Stake in Alaunos Therapeutics, Inc. (Nasdaq: TCRT)

TCRT

Apr 29, 2025, 12:15 PM EDT - 7 months ago

RESEND - Northstrive Biosciences Strengthens IP Portfolio with New US Patent Filings for EL-22 and EL-32 Programs Covering Obesity and Animal Health

Apr 28, 2025, 8:00 AM EDT - 7 months ago

Northstrive Biosciences Co-Founder Featured on Bear Bull Traders Following Announcement of Positive FDA Response Supporting Submission of IND for EL-22 Phase 2 Clinical Trial

Apr 16, 2025, 8:00 AM EDT - 8 months ago

PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based Custom IT Packaging Company

Apr 7, 2025, 5:30 PM EDT - 8 months ago

Nestpoint Group Fuels Univest Securities, LLC's Ascent to Investment Banking Powerhouse in Trump's Economic Golden Age

BON

Mar 28, 2025, 8:00 AM EDT - 9 months ago

PMGC Holdings Inc. Announces Filing of Annual Report on Form 10-K

Mar 27, 2025, 8:00 AM EDT - 9 months ago

NorthStrive Biosciences Inc. Signs Amended Licensing Agreement with Existing Licensor, Aims to Capture Animal Health Market

Mar 24, 2025, 5:00 PM EDT - 9 months ago

Univest Securities, LLC Announces Closing of $1.48 Million Registered Direct Offering for its Client PMGC Holdings Inc. (NASDAQ: ELAB)

Mar 21, 2025, 2:41 PM EDT - 9 months ago

PMGC Holdings Inc. Announces $1.48 Million Registered Direct Offering Priced At-The Market Under Nasdaq Rules

Mar 21, 2025, 8:00 AM EDT - 9 months ago

PMGC Holdings Announces Share Repurchases from Existing Shareholders

Feb 27, 2025, 8:00 AM EST - 10 months ago

PMGC Holdings Inc. Expands Investment & M&A Efforts, Actively Seeking Acquisitions and Investments Through Strategic Sponsorship of TCA Venture Group

Feb 26, 2025, 8:30 AM EST - 10 months ago

PMGC Holdings Highlights Strong Capital Position: No Debt, Fully Funded, and Warrants Priced Above Market

Feb 4, 2025, 8:00 AM EST - 10 months ago

Northstrive Biosciences, Inc., a Subsidiary of PMGC Holdings Inc., Reports Positive Updates for Obesity Drug Candidates Targeting Fat Loss and Muscle Preservation used in Combination with GLP-1

Jan 31, 2025, 10:33 AM EST - 11 months ago

PMGC Capital LLC, a subsidiary of PMGC Holdings Inc., Begins to Build Portfolio with Strategic Acquisition of shares in U.S.-Focused Uranium Energy and Fire Prevention Technology Companies

Jan 28, 2025, 5:00 PM EST - 11 months ago

Univest Securities, LLC Announces Closing of $1.92 Million Warrant Inducement for its Client PMGC Holdings Inc. (NASDAQ: ELAB)

Jan 27, 2025, 9:00 AM EST - 11 months ago

PMGC Holdings Inc. Announces $1.9 Million in Gross Proceeds from Warrant Inducement with Institutional Investors

Jan 24, 2025, 8:00 AM EST - 11 months ago

Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., to Present Breakthrough Muscle Preservation Asset at Exclusive UCLA Obesity Symposium

Jan 16, 2025, 8:31 AM EST - 11 months ago

PMGC Holdings Inc. Announces Closing of Elevai Skincare Divestiture

Jan 15, 2025, 9:30 AM EST - 11 months ago

PMGC Holdings Inc. Announces Name Change of Wholly Owned Subsidiaries

Jan 2, 2025, 3:55 PM EST - 1 year ago

PMGC Holdings Inc. Following Skincare Subsidiary Sale, Embarks on Bold Growth Strategy

Dec 20, 2024, 7:30 PM EST - 1 year ago

Elevai Labs Inc. Announces Name Change to PMGC Holdings Inc. and Redomicile to Nevada

Dec 20, 2024, 7:30 AM EST - 1 year ago

Elevai Labs Inc. Announces Anticipated Name Change to PMGC Holdings Inc. and Redomicile to Nevada

Dec 6, 2024, 7:30 AM EST - 1 year ago

Elevai Labs Inc. Subsidiary, Elevai Skincare, Launches S-Series Root Renewal System, Marking Entry into Hair Care Market

Nov 22, 2024, 6:23 PM EST - 1 year ago

Elevai Labs Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing Compliance

Nov 22, 2024, 5:00 PM EST - 1 year ago

Elevai Labs Inc. Announces Withdrawal of Offer to Exchange and Plans to Reassess

Nov 14, 2024, 2:35 PM EST - 1 year ago

CORRECTION - Elevai Labs Inc.

Nov 14, 2024, 9:08 AM EST - 1 year ago

Elevai Labs Inc. Reports Financial Results for the Second Fiscal Quarter of 2024 and Provides Business Update

Nov 4, 2024, 5:45 PM EST - 1 year ago

Elevai Labs Inc. Announces Update and Extension of Pending Offer to Exchange

Oct 22, 2024, 9:54 AM EDT - 1 year ago

Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Engages Leading Contract Research Organization (CRO) to Support Regulatory Planning Efforts and Pre-IND Meeting with the Food and Drug Administration For EL-22 For The Treatment of Obesity

Oct 21, 2024, 7:30 AM EDT - 1 year ago

Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Highlights Past Positive Preclinical Data Showing Potential of EL-32, A Dual Myostatin & Activin-A Blocker, For the Treatment of Obesity

Oct 4, 2024, 5:08 PM EDT - 1 year ago

Elevai Labs Inc. Commences Offer to Exchange Up to 15,000,000 shares of Common Stock For Shares of Non Tradable. Locked Up Series B Preferred Stock

Oct 3, 2024, 3:45 PM EDT - 1 year ago

REPEAT: Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist Combinations

Oct 3, 2024, 7:30 AM EDT - 1 year ago

Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist Combinations

Oct 2, 2024, 8:30 AM EDT - 1 year ago

Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Launch of Clinical Study Combining Its Flagship Topical Exosome Skincare Products with a Medical Aesthetic Energy Device